# STRIKE (NCT06661720)

> Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06661720
- Phase: PHASE3
- Status: RECRUITING
- Sponsor: Alliance for Clinical Trials in Oncology
- Conditions: Clear Cell Renal Cell Carcinoma; Renal Cell Carcinoma (RCC); Stage II Renal Pelvis Cancer AJCC v8; Stage III Renal Pelvis Cancer AJCC v8
- Interventions: Pembrolizumab; Tivozanib; Biospecimen Collection; MRI; Computed Tomography; Biopsy; Questionnaire Administration
- Enrollment: 1040
- Primary outcome: Disease-free survival (DFS)

## Indexed commentary on STRIKE so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=strike-nct06661720